Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(2,4-dichloro-beta-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole
2. Fenizolan
3. Fenticonazole
4. Fenticonazole Mononitate
5. Laurimic
6. Lomexin
7. Micofulvin
8. Rec 15-1476
9. Terlomexin
1. 73151-29-8
2. Lomexin
3. Falvin
4. Fenticonazole Mononitrate
5. Fenticonazole (nitrate)
6. Rec 15/1476
7. Fenticonazole Nitrate [usan]
8. Rec 15-1476
9. 8v4jgc8yrf
10. 1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole;nitric Acid
11. Chebi:83606
12. Alpha-(2,4-dichlorophenyl)-beta,n-imidazolylethyl-4-phenylthiobenzyl Ether Nitrate
13. (+-)-1-(2,4-dichloro-beta-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole Mononitrate
14. 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)-1h-imidazole Nitrate
15. Fenticonazole Nitrate (usan)
16. Fenticonazole Nitrate 100 Microg/ml In Acetonitrile
17. Lomexin Nitrate
18. Einecs 277-302-6
19. Unii-8v4jgc8yrf
20. Gynoxin
21. Fenticonazolnitrat
22. Lomexin (tn)
23. Tx 15338
24. 1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole; Nitric Acid
25. Rec-151476b Free Base
26. Schembl362708
27. Chembl2107703
28. Dtxsid30993890
29. Rec-151476
30. Bcpp000232
31. Hms3655j11
32. Bcp26349
33. Hy-b0359
34. Ac-426
35. Mfcd00941391
36. S2031
37. Fenticonazole Mononitrate [mi]
38. Fenticonazole Nitrate [mart.]
39. Akos015855521
40. Fenticonazole Nitrate [who-dd]
41. Bcp9000681
42. Ccg-269839
43. 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-1h-imidazolium Nitrate
44. 1-(2-(2,4-dichlorophenyl)-2-((4-phenylsulfanylphenyl)methoxy)ethyl)imidazole Nitrate
45. Imidazole, 1-(2,4-dichloro-beta-(p-(phenylthio)benzyloxy)phenethyl)-, Nitrate
46. Rec-15/1476
47. 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-, (+-)-, Mononitrate
48. As-18687
49. 2,2,3,3,4,5-hexachlorobiphenyl
50. Fenticonazole Nitrate [ep Monograph]
51. F1008
52. Ft-0630820
53. Ft-0654253
54. Sw219219-1
55. D02583
56. A837734
57. Q27157007
58. 1-(2-(2,4-dichlorophenyl)-2-(4-(phenylthio)benzyloxy)ethyl)-1h-imidazole Nitrate
59. 1-[2-(2,4-dichlorophenyl)-2-[[4-(phenylthio)phenyl]methoxy]ethyl]imidazole; Nitric Acid
60. (+/-)-1-(2,4-dichloro-.beta.-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole Mononitrate
61. 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-, (+/-)-, Mononitrate
62. Nitric Acid--1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)phenyl]methoxy}ethyl]-1h-imidazole (1/1)
63. Rac-1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]-1h-imidazole Nitrate
Molecular Weight | 518.4 g/mol |
---|---|
Molecular Formula | C24H21Cl2N3O4S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 8 |
Exact Mass | 517.0629827 g/mol |
Monoisotopic Mass | 517.0629827 g/mol |
Topological Polar Surface Area | 118 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 524 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceutical products to Japan. In 2006, it acquired Pharmasynthèse. Today, Inabata...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
About the Company : PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipients for pharmaceuti...
About the Company : Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent ...
About the Company : OM Pharmaceutical Industries is one of the established pharmaceutical company in India, which is engaged in manufacturing of Active Pharmaceutical Ingredients (API) and intermediat...
About the Company : Shouyuan chemical (one of the leading chemicals supplier in China) specializes in manufacturing, supplying, and custom synsthesis latest chemicals. Our products cover all kinds of ...
About the Company : Our work in the distribution sector starts and ends with the quality of human relations; first and foremost, it is trust that we want to build with you. The connections we build ar...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
36
PharmaCompass offers a list of Fenticonazole Nitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fenticonazole Nitrate manufacturer or Fenticonazole Nitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fenticonazole Nitrate manufacturer or Fenticonazole Nitrate supplier.
PharmaCompass also assists you with knowing the Fenticonazole Nitrate API Price utilized in the formulation of products. Fenticonazole Nitrate API Price is not always fixed or binding as the Fenticonazole Nitrate Price is obtained through a variety of data sources. The Fenticonazole Nitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lomexin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lomexin, including repackagers and relabelers. The FDA regulates Lomexin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lomexin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lomexin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lomexin supplier is an individual or a company that provides Lomexin active pharmaceutical ingredient (API) or Lomexin finished formulations upon request. The Lomexin suppliers may include Lomexin API manufacturers, exporters, distributors and traders.
click here to find a list of Lomexin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lomexin DMF (Drug Master File) is a document detailing the whole manufacturing process of Lomexin active pharmaceutical ingredient (API) in detail. Different forms of Lomexin DMFs exist exist since differing nations have different regulations, such as Lomexin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lomexin DMF submitted to regulatory agencies in the US is known as a USDMF. Lomexin USDMF includes data on Lomexin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lomexin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lomexin suppliers with USDMF on PharmaCompass.
A Lomexin CEP of the European Pharmacopoeia monograph is often referred to as a Lomexin Certificate of Suitability (COS). The purpose of a Lomexin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lomexin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lomexin to their clients by showing that a Lomexin CEP has been issued for it. The manufacturer submits a Lomexin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lomexin CEP holder for the record. Additionally, the data presented in the Lomexin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lomexin DMF.
A Lomexin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lomexin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Lomexin suppliers with CEP (COS) on PharmaCompass.
A Lomexin written confirmation (Lomexin WC) is an official document issued by a regulatory agency to a Lomexin manufacturer, verifying that the manufacturing facility of a Lomexin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lomexin APIs or Lomexin finished pharmaceutical products to another nation, regulatory agencies frequently require a Lomexin WC (written confirmation) as part of the regulatory process.
click here to find a list of Lomexin suppliers with Written Confirmation (WC) on PharmaCompass.
Lomexin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lomexin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lomexin GMP manufacturer or Lomexin GMP API supplier for your needs.
A Lomexin CoA (Certificate of Analysis) is a formal document that attests to Lomexin's compliance with Lomexin specifications and serves as a tool for batch-level quality control.
Lomexin CoA mostly includes findings from lab analyses of a specific batch. For each Lomexin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lomexin may be tested according to a variety of international standards, such as European Pharmacopoeia (Lomexin EP), Lomexin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lomexin USP).